• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于老年临床I期非小细胞肺癌患者,进行系统性淋巴结清扫以准确分期是否值得?

Is systemic node dissection for accuracy staging in clinical stage I non-small cell lung cancer worthwhile in the elderly?

作者信息

Iwasaki A, Hamatake D, Hamanaka W, Hamada T, Shirakusa T, Yamamoto S, Shiraishi T

机构信息

Department of Thoracic Surgery, School of Medicine, Fukuoka University, Fukuoka, Japan.

出版信息

Thorac Cardiovasc Surg. 2008 Feb;56(1):37-41. doi: 10.1055/s-2007-965057.

DOI:10.1055/s-2007-965057
PMID:18200466
Abstract

OBJECTIVE

The therapeutic role of systematic node dissection (SND) for early lung cancer remains controversial. Elderly patients have a background of insufficient physiological function and comorbidity, and a shorter life expectancy than that of younger patients. Therefore, we have evaluated the impact on survival, local recurrence, and complications of not performing systematic lymph node dissection in the elderly.

METHODS

A retrospective analysis of 126 patients, including the elderly (75 - 89 years), who underwent a lobectomy for clinical stage I was performed. The patients were grouped according to node dissection numbers after surgery, and finally separated into two groups (SG: sufficient group, dissections of more than 10 nodes and 3 or more mediastinal stations; IG: insufficient group, less than 10 nodes and one or two mediastinal stations). Postoperative morbidity and sites of recurrence were evaluated between the two groups, and the survival rates were analyzed at 5 years.

RESULTS

Upstage was identified in 12.6% of patients: 7.3% in IG (n = 45), 15.2% in SG (n = 86). Postoperative mortality occurred in 2 cases (1.58%). The incidence of postoperative respiratory or cardiac complications was more frequent in the SG, while there were fewer complications in the IG. There was no significant difference in recurrence rates between the two groups. Both local and distant recurrence was observed in the two groups. The 5-year survival rates were 61.5% for the SG and 59.4% for the IG. There was no significant difference in the survival rate between the IG and SG patients.

CONCLUSIONS

Proper staging and the avoidance of nontherapeutic lymph node dissection seems acceptable for clinical stage I lung cancer in the group of elderly patients.

摘要

目的

系统性淋巴结清扫术(SND)对早期肺癌的治疗作用仍存在争议。老年患者存在生理功能不足和合并症的背景,预期寿命比年轻患者短。因此,我们评估了不对老年患者进行系统性淋巴结清扫对生存、局部复发和并发症的影响。

方法

对126例临床I期接受肺叶切除术的老年患者(75 - 89岁)进行回顾性分析。根据术后淋巴结清扫数量对患者进行分组,最终分为两组(SG:充分组,清扫淋巴结超过10个且纵隔站数为3个或更多;IG:不充分组,清扫淋巴结少于10个且纵隔站数为1个或2个)。评估两组之间的术后发病率和复发部位,并分析5年生存率。

结果

12.6%的患者出现分期上调:IG组(n = 45)为7.3%,SG组(n = 86)为15.2%。术后死亡2例(1.58%)。SG组术后呼吸或心脏并发症的发生率更高,而IG组并发症较少。两组之间的复发率无显著差异。两组均观察到局部和远处复发。SG组的5年生存率为61.5%,IG组为59.4%。IG组和SG组患者的生存率无显著差异。

结论

对于老年患者中的临床I期肺癌,适当分期并避免进行非治疗性淋巴结清扫似乎是可以接受的。

相似文献

1
Is systemic node dissection for accuracy staging in clinical stage I non-small cell lung cancer worthwhile in the elderly?对于老年临床I期非小细胞肺癌患者,进行系统性淋巴结清扫以准确分期是否值得?
Thorac Cardiovasc Surg. 2008 Feb;56(1):37-41. doi: 10.1055/s-2007-965057.
2
Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.非小细胞肺癌完全切除术后纵隔淋巴结清扫与系统采样后的发病率、生存率及复发部位
Ann Thorac Surg. 2005 Jul;80(1):268-74; discussion 274-5. doi: 10.1016/j.athoracsur.2005.02.005.
3
Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.临床手术分期为I期的非小细胞肺癌的选择性纵隔淋巴结清扫术
Ann Thorac Surg. 2006 Mar;81(3):1028-32. doi: 10.1016/j.athoracsur.2005.09.078.
4
Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.前哨淋巴结取样限制了I期非小细胞肺癌的淋巴结清扫术。
Eur J Cardiothorac Surg. 2007 Aug;32(2):356-61. doi: 10.1016/j.ejcts.2007.04.030. Epub 2007 May 21.
5
[Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].[不同纵隔淋巴结清扫术对临床ⅠA期非小细胞肺癌的影响]
Zhonghua Wai Ke Za Zhi. 2008 May 1;46(9):670-3.
6
Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.非小细胞肺癌最高纵隔淋巴结转移的预后意义
Ann Thorac Surg. 2006 Jan;81(1):292-7. doi: 10.1016/j.athoracsur.2005.06.077.
7
Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?淋巴结清扫范围是否会影响I期非小细胞肺癌患者的预后?
Eur J Cardiothorac Surg. 2005 Apr;27(4):680-5. doi: 10.1016/j.ejcts.2004.12.035.
8
Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?胸腔镜下肺叶切除术联合系统性淋巴结清扫术治疗淋巴结阳性非小细胞肺癌——胸腔镜下淋巴结清扫术可行吗?
Thorac Cardiovasc Surg. 2008 Apr;56(3):162-6. doi: 10.1055/s-2007-989368.
9
Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.基于肺叶特异性淋巴结转移模式的选择性淋巴结清扫对可切除非小细胞肺癌患者生存结局的影响:应用倾向评分的大规模回顾性队列研究
J Thorac Cardiovasc Surg. 2010 Apr;139(4):1001-6. doi: 10.1016/j.jtcvs.2009.07.024. Epub 2009 Sep 5.
10
[Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].[临床I a期非小细胞肺癌淋巴结清扫的适宜范围]
Ai Zheng. 2007 Mar;26(3):303-6.

引用本文的文献

1
Nodal involvement pattern in resectable lung cancer according to tumor location.根据肿瘤位置的可切除性肺癌的淋巴结受累模式。
Cancer Manag Res. 2012;4:151-8. doi: 10.2147/CMAR.S30526. Epub 2012 Jun 7.
2
Safety and prognosis of limited surgery for octogenarians with non-small-cell lung cancer.八旬非小细胞肺癌患者有限手术的安全性及预后
Gen Thorac Cardiovasc Surg. 2012 Feb;60(2):97-103. doi: 10.1007/s11748-011-0880-3. Epub 2012 Feb 12.